Insiders who reported open-market trades in the last 12 months at the companies Verneuil Vanina de files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Verneuil Vanina de is a corporate insider, tracked as EVP, General Counsel, Corp Sec of Vir Biotechnology, Inc. (VIR). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Verneuil Vanina de last file a Form 4?
The most recent primary Form 4 on record is dated 26 February 2026, one of 7 filings going back to 2024.
Has Verneuil Vanina de been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($295K) across all tracked filings.
Verneuil Vanina de is EVP, General Counsel, Corp Sec of Vir Biotechnology, Inc. (VIR). 7 SEC Form 4 filings on record going back to 2024, most recently on 26 February 2026. Most recent open-market trade: sold $135K of VIR on 26 February 2026. Lifetime open-market sales: $295K.
Recent transactions
10
The latest 10 SEC Form 4 transactions reported by Verneuil Vanina de.
InsiderAlpha's records for Verneuil Vanina de go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. 10 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
